Skip to content
Screener

Bioventus BVS EV / EBITDA

EV / EBITDA at other companies

Stryker logo
StrykerSYK
22.1×-11.8×
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
10.3×-0.7×
Xtant Medical Holdings logo
Xtant Medical HoldingsXTNT
7.2×—
Medtronic logo
MedtronicMDT
13.9×-1.5×
Globus Medical logo
Globus MedicalGMED
11.2×-2.9×
Enovis logo
EnovisENOV
24.9×-0.6×

Other financials

Income statement

See full
Revenue$153.2M+3.8%
Gross profit$105.7M+3.5%
Operating income$19.1M+4.1%
Net income$33.4M+348%
EPS (diluted)$0.47+327%

Balance sheet

See full
Cash & equivalents$29.5M-10.5%
Total debt$263.7M-26.9%
Total equity$228.3M+41.6%
Total assets$673.3M-4.7%

Cash flow

See full
Operating cash flow$19.9M-23.4%
CapEx$960.0K+40.6%
Free cash flow$18.9M-25.1%

Valuation

See full
Market cap$1.19B+156%
Enterprise value$1.42B+79.7%
P/E21.8×—
P/S2×+1.2×

Profitability

See full
Gross margin68.7%+1.1pp
Operating margin10%—
Net margin9.4%+9.2pp
FCF margin16.2%+10.2pp

Returns & leverage

See full
Return on equity28%+27.5pp
Debt / equity1.2×-1.1×
Current ratio1.7×+0.2×

Where this comes from

Calculated from Bioventus’s reported figures.

enterprise value/ebitda=8.4×

Based on the most recent quarter.

The source filing: Bioventus’s 10-Q, filed August 5, 2026. Open the filing →

Filed
Aug 5, 2026, 7:43 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001665988-26-000042

FAQ

What is Bioventus's EV / EBITDA?
Bioventus (BVS) reported EV / EBITDA of 8.4× in Q2 2026.
How has Bioventus's EV / EBITDA changed year-over-year?
Bioventus's EV / EBITDA decreased by 27.8% year-over-year, from 11.7× to 8.4×.
What does EV / EBITDA mean?
Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.

Ask your AI about Bioventus's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude